Among Targeting Microbiota 2016 VIP Speakers

Bioinformatics, integrating clinical and microbiome data: the challenge.
Examples from gut, oral and nasal microbiota in Parkinson’s disease
Velma Aho, University of Helsinki, Finland

Transition from an infant- to adult-like gut microbiota – where do the bacteria come from?
Ekaterina Avershina, Norway University of Life Sciences, Norway

Changing of skin and gut Microbiotas in ordinary life: cosmetics and bowel
Lorenzo Drago, University of Milan, Italy

Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?
Paul Forsythe, McMaster University, Canada

Lactobacillus rhamnosus GG intake modifies preschool children’s intestinal microbiota, alleviates penicillin-associated changes and reduces antibiotic use
Katri Korpela, Helsinki University, Finland

Age-related immune senescence and microbiota dysbiosis: lessons from the fly
Henri Jasper, University of Rochester, USA

Impact of microbiota on odorant detection and olfactory preferences in mice
Nicolas Meunier, Neurobiologie de l'Olfaction et Blosenseur (NBO), INRA, France

Functional Redundancy-Induced Stability of Gut Microbiota Subjected to Disturbance
Andrés Moya, University of Valencia, Spain

Faecalibacterium prausnitzii dynamics in the human gut microbiome underlying atopic dermatitis
Heenam Stanley Kim, Korea University, Republic of Korea

Maternal microbiota sets neonatal innate immune system development
Mercedes Gomez de Agüero, University of Bern, Switzerland

Microbiota & Bioinformatics: Strategic Targets
Sean Kennedy, 
Institut Pasteur, Paris

Emerging role of fecal microbiota therapy in the treatment of gastrointestinal diseases
Peter C. Konturek, Thuringia-Clinic Saalfeld, Germany

Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics
Roberto Pacifici, Emory University School of Medicine, USA

Tools and approaches to achieve strain resolution analyses of the microbiota
The gut microbiota mobilome and the potential of pathogen transmission of antibiotic resistance
Knut Rudi, Norway University of Life Sciences, Norway

Efficacy and mechanisms of action of fecal microbiota transplantation in ulcerative colitis: Pitfalls and promises from a first meta-analysis
Franco Scaldaferri,
Catholic University of Sacred Hearth, Italy

Bacteriophages for improving human health: from food additives to dietary supplements
Alexander Sulakvelidze, Intralytix, USA

Mammals shape their microbiome to prevent disease: Recent Scientific advances & Perspectives
Howard Weiner, Harvard Medical School, USA

Important human microbial ecological system modulator - FMT (fecal microorganism transplantation) or one of the best clinical applications of epigenetics in gastroenterology
Diana Zandere, University of Riga, Latvia

Bacteriocin from epidemic Listeria strains alters the host intestinal microbiota to favor infection 
Juan-Jose Quereda, Institut Pasteur, France

Response of gut bacteria to host starvation: understanding the risk factos to develop an eating disorder 
Serguei Fetissov, Rouen University, France


To access to the preliminary program, please click here

Microbiota in the Press & Media

  • 1
  • 2
  • 3
Prev Next